Companies ›Health Care ›RWB.CD

RWB.CD — — Healthcare Facilities & Services

Red White & Bloom Brands Inc.

$0,04

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

—

ROE

—

Net margin

—

Debt / equity

-1,75

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

RWB.CD operates in the Healthcare sector, specifically in the Pharmaceuticals activity, and generates revenue through its operations in Healthcare Facilities & Services.

Business. RWB.CD is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability

—

not yet wired

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning RWB.

Sector rotation

Sector1D1Mvs mkt

Communication Services+2,2 %−5,5 %+1,5 %

Materials+2,2 %+3,1 %+1,4 %

Energy+0,9 %+5,2 %+0,1 %

Health Care · THIS SECTOR+0,8 %−1,3 %−0,0 %

Consumer Discretionary+0,3 %+9,2 %−0,5 %

Information Technology+0,2 %+8,1 %−0,6 %

Financials−0,3 %−2,8 %−1,0 %

Consumer Staples−0,6 %+3,2 %−1,4 %

Real Estate−0,7 %+10,9 %−1,5 %

Industrials−1,1 %−0,3 %−1,8 %

Utilities−1,9 %+28,2 %−2,6 %

Developing storylines

No tracked sagas currently linked to RWB.CD. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-07-26 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

RWB.CD is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

AI synthesis

GENERATED

RWB.CD has a negative equity position of -240,968,000 CAD, indicating a significant debt burden relative to its equity base. The company's liquidity position is further strained by a cash and equivalents balance of 4,567,000 CAD, which is insufficient to cover its long-term debt of 420,685,000 CAD. The debt-to-equity ratio of -1.75 suggests that the company is financed more by debt than equity, which could pose a risk to its financial stability.

In terms of profitability, RWB.CD reported a negative operating cash flow of -9,565,000 CAD, indicating that the company is not generating sufficient cash from its operations to sustain its activities. The company's return on invested capital (ROIC) and other profitability metrics are not provided, but the negative operating cash flow suggests that the company is not currently generating positive returns on its investments.

RWB.CD's revenue is concentrated in a single segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not specified, but the negative operating cash flow and high debt levels suggest that it may be vulnerable to regional economic downturns.

The company's growth trajectory is uncertain, as the available data does not provide a clear indication of future revenue growth. The negative operating cash flow and high debt levels suggest that the company may face challenges in sustaining its operations and growing its revenue.

The risk assessment indicates that RWB.CD has a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag that highlights its financial instability. The dilution risk is low, but the company's high debt levels and negative equity position could lead to further dilution if it needs to raise additional capital.

Recent events and filings do not provide specific details on the company's operations or financial performance. The negative operating cash flow and high debt levels suggest that the company may be facing financial challenges that could impact its ability to meet its obligations.

Key takeaways

RWB.CD has a negative equity position, indicating a significant debt burden relative to its equity base.
The company's liquidity position is strained, with a cash and equivalents balance insufficient to cover its long-term debt.
RWB.CD reported a negative operating cash flow, suggesting it is not generating sufficient cash from its operations to sustain its activities.
The company's growth trajectory is uncertain, with no clear indication of future revenue growth.
The risk assessment indicates a medium liquidity risk and a low dilution risk, with a key flag highlighting the company's financial instability.
**margin_outlook_rationale**: The company's negative operating cash flow suggests that its margins are currently under pressure due to high operating costs and low revenue.
**rd_outlook_rationale**: No specific information is available on the company's research and development activities or their impact on future growth.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

$0,04

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

—

Net cashⓘ

-$416.1M

Current ratioⓘ

—

Debt / equityⓘ

-1.8

ROAⓘ

—

ROEⓘ

—

Cash conversionⓘ

—

CapEx / revenueⓘ

-8.3%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Capex / Rev-8,3 %Below median

D/E-1,75Best in class

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Debt To Equity
(short_term_debt + long_term_debt) / total_equity

Source documents

RWB.CD Market data — financials · 2026-05-29
Red White & Bloom Brands Inc Market data — analyst estimates · 2026-05-29

Ownership & reference

Leadership

Colby De ZenPresident, Director

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

RWB.CDCanonical

— · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-26 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread